Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.
Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.
Using RFA to treat tumors in 26 patients with biopsy-proven T1 and T2 breast carcinoma, researchers in Italy and at the University of Texas M.D. Anderson Cancer Center aimed for complete ablation and a 5-mm margin. They achieved complete tumor necrosis in 25 of 26 patients, or 96%.
Traditional surgery, such as lumpectomy, usually takes about an hour. Researchers reported a mean treatment time for two-phase RFA of 15 minutes and 23 seconds.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.